Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Motilin Receptor-MA-2029
MA-2029

Chemical Structure : MA-2029

CAS No.: 287206-61-5

MA-2029 (MA2029)

Catalog No.: PC-22029Not For Human Use, Lab Use Only.

MA-2029 (MA2029) is a potent, selective and competitive motilin receptor (GPR38) antagonist with pA2 value of 9.17, displays [125I]motilin with IC50 of 2.74 nM.

Packing Price Stock Quantity
5 mg $478 In stock
10 mg $788 In stock
25 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

MA-2029 (MA2029) is a potent, selective and competitive motilin receptor (GPR38) antagonist with pA2 value of 9.17, displays [125I]motilin with IC50 of 2.74 nM.
MA-2029 (1 µM) has no effects on resting tone or spontaneous contractions and no significant effect on the contractile response to acetylcholine or substance P.
MA-2029 also displaces [125I] motilin bound to cell membranes of HEK 293 cells expressing human motilin receptors with IC50 and pKi values of 4.9 nM and 8.39, respectively.
MA-2029 shows either very low or no affinity for any of the 24 receptors and 7 ion channels.
MA-2029 (3 to 30 mg/kg, oral) dose-dependently inhibited colonic contractions induced by motilin (3 μg/kg, i.v.) in conscious rabbits.
MA-2029 (0.3 to 3 mg/kg) also inhibited abdominal muscle contractions (an index of the visceral pain) induced by intravenous infusion of motilin (3 μg/kg/h) during colorectal distension in conscious rabbits.

Physicochemical Properties

M.Wt 538.73
Formula C31H46N4O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(S)-N-[(S)-2-(3-tert-Butyl-4-hydroxy-phenyl)-1-ethylcarbamoyl-ethyl]-3-methyl-2-[methyl-((S)-2-methylamino-3-phenyl-propionyl)-amino]-butyramide

References

1. Sudo H, et al. Eur J Pharmacol. 2008 Mar 10;581(3):296-305.

2. Ozaki K, et al. Eur J Pharmacol. 2009 Aug 1;615(1-3):185-92.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: